Rapid-onset opioids for the treatment of breakthrough cancer pain: Two cases of drug abuse

Roberta Granata, Paolo Bossi, Rossella Bertulli, Luigi Saita

Research output: Contribution to journalArticle

Abstract

Setting: In the last few years, the use of opioids for cancer pain has rapidly increased and new molecules have been developed. Currently, rapid-onset opioids are widely used in clinical practice for breakthrough cancer pain (BTcP). However, the tolerability of these molecules is still a matter of debate. Patients: We describe two cases of rapid-onset opioids misuse that have been recently observed at our palliative care unit. Discussion: The reported cases are explicative as they occurred in patients suffering from different types of cancer and with different causes of BTcP. Further investigations are needed to identify factors predicting addiction to this new class of molecules.

Original languageEnglish
Pages (from-to)758-761
Number of pages4
JournalPain Medicine (United States)
Volume15
Issue number5
DOIs
Publication statusPublished - 2014

Keywords

  • Abuse
  • Breakthrough cancer pain
  • Rapid-onset opioids

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Rapid-onset opioids for the treatment of breakthrough cancer pain: Two cases of drug abuse'. Together they form a unique fingerprint.

  • Cite this